C

Crispr Therapeutics

Biotechnology Research · United States · 500 employees

64 Decision makers
+5 New (6 months)
500 Employees
$13M Revenue
2013 Founded

Organizational Chart of Crispr Therapeutics

Roles identified within Crispr Therapeutics's leadership team, from public professional data, updated 25 Oct 2026.

Department

Hiring This department is actively hiring right now.

Crispr Therapeutics's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Crispr Therapeutics by function

General management

Finance

Human resources

Other functions

See all Crispr Therapeutics contacts on Zeliq

Decision makers at Crispr Therapeutics

64 identified 3 C-Level 5 VP 56 Directors +5 new (6 months)
See them on Zeliq →

Departments actively hiring 1 department

General management

These departments at Crispr Therapeutics are actively recruiting: a strong signal to time your outreach.

Funding and news at Crispr Therapeutics

Funding

Last round Other · $550M
Total funding $957M (7 rounds)
Series A $25M Apr 2014
Series A $35M Apr 2015
Series B $29M Apr 2015
Series B $38M Jun 2016
Grant N/A Dec 2020
Post-IPO Equity $280M Feb 2024
Post-IPO Debt $550M Mar 2026

Latest news at Crispr Therapeutics

  1. Appointment

    New Associate Director appointed — General management

  2. Appointment

    New Director appointed — General management

  3. Appointment

    New Sr. Director, Controller appointed — Finance & accounting

  4. Appointment

    New Executive Director appointed — General management

Get these new hires' email and phone →

Team Structure headcount by department

Research
99
Operations
48
Medical
28
Other
26
Technical
25
Hiring General Management
23
Finance
12
Project Management
9

How to prospect Crispr Therapeutics's departments

Research

This is where the company's largest headcount sits (99 people). Data quality and reproducibility are core concerns: a strong angle if your offer touches either.

Operations

The company's second-largest department (48 people). Operations leaders live in the concrete: a pilot scoped on one process will convince more than a demo.

Medical

A team of 28 people. Medical teams trust peer references: name comparable organisations you already serve.

Other

This department counts 26 people. A cross-functional team where use cases vary: qualify the actual roles before tailoring your pitch.

Technical

25 people work in this department. Technical teams verify claims: public docs, a sandbox or a free tier will do the selling for you.

General Management

A team of 23 people, currently hiring. General management thinks in strategic priorities: link your value proposition to one of theirs or you will not get a reply.

Try the Zeliq email finder demo →

FAQ Crispr Therapeutics

Who runs Crispr Therapeutics?

The highest-ranking leadership role identified at Crispr Therapeutics is “CFO”, based on public data updated 25 Oct 2026.

How many decision makers does Crispr Therapeutics have?

64 decision makers identified, including 3 at executive level.

How do I contact a decision maker at Crispr Therapeutics?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Which departments are hiring at Crispr Therapeutics?

General management, based on published job offers as of 25 Oct 2026.

Companies similar to Crispr Therapeutics

More companies to explore

Biotechnology Research · United States

All Biotechnology Research companies in United States →

About Crispr Therapeutics

Crispr Therapeutics is a Biotechnology Research company, based in United States. Established in 2013, it has a workforce of roughly 500 people. As part of the broader Professional Services sector, Crispr Therapeutics operates specifically in the Biotechnology Research segment. Crispr Therapeutics is a B2B company, primarily serving business clients and professional organisations. To date, Crispr Therapeutics has completed 7 funding rounds totalling $957M. The company generates approximately $13M in annual revenue. Use this page to review Crispr Therapeutics's industry, headcount, location and hiring signals, and to reach verified B2B contacts before your next outreach.

Activity & Market

The company evolves in the Biotechnology Research segment of the Professional Services sector. As a B2B company, Crispr Therapeutics primarily serves business clients and professional organisations. The company is categorised as “Public company”.